To make money investing in marijuana businesses, you need to appreciate the industry trends and act accordingly. But not every trend that’s claimed to be harkening the arrival of Cannabis 2.0 is actionable, some trends are just noise.
Let’s examine two of the most important trends in cannabis so you’ll understand how to evaluate companies’ plans and stock performance in the appropriate context.
© Getty Images Inspecting cannabis plants.1. Falling valuations
In my view, the most under-discussed trend in cannabis stocks right now is their falling valuations.
Consider the following chart of cannabis industry leaders Trulieve Cannabis (OTC: TCNNF), Cresco Labs, OrganiGram Holdings, Curaleaf Holdings, and Tilray Brands:
© YCharts TCNNF PS Ratio
As you can see, these five leading marijuana companies have experienced marked drops in their price-to-sales (P/S) ratios over the last two years, bringing them closer to the market’s average P/S near 3. In the same period, the trailing-12-month revenue of each of these companies has posted moderate to extremely rapid growth.
© YCharts TCNNF Revenue (TTM)
Since revenues aren’t falling, plummeting stock prices are the cause of deflating valuations. Uncertainty over rising interest rates has been driving a general downturn in growth stocks, and cannabis stocks have been hit especially hard. Even shares of profitable competitors like Trulieve faced a decline of more than 55% in the last 12 months. Of course, deeply unprofitable businesses like Tilray were hit even harder, falling by more than 66%.
So investors now have an opportunity to buy quality cannabis cultivators at a relative bargain, and it’s unlikely that valuations will return to their prior heights anytime soon. Just be aware that stocks with more-grounded valuations might be less vulnerable to sharp drops when people are fleeing to value in times of market turbulence.
Video: Tailwinds will eventually come for cannabis stocks, says Canaccord Genuity’s Bottomley (CNBC)
Tailwinds will eventually come for cannabis stocks, says Canaccord Genuity’s Bottomley
What to watch next
U.S. weekly jobless claims fall well below estimates to 166,000
CNBC
Fanatics is going through a pretty fast transformation, says CEO Michael Rubin
CNBC
The Pre-Market Rundown 2: April 07, 2022
CNBC
Ron Baron on investing in Tesla: We expect to make up to five times our money over the next decade
CNBC
Volatility is not always bad, take advantage of the movements, says Citi’s Kristen Bitterly
CNBC
Rep. Debbie Dingell on gas prices: People are being gouged and need help
CNBC
We cannot have ‘foreign enclaves’ within France, says Le Pen spokesperson
CNBC
Le Pen and Zemmour stand with Putin, argues Les Republicains lawmaker ahead of French election
CNBC
GM ramps up production of all-electric GMC Hummer, reports more than 65,000 reservations
CNBC
Stoltzfus: It’s quite normal for the market to react adversely as the Fed begins a tightening cycle
CNBC
Tiger Woods makes a remarkable return to the Masters, but can he contend?
CNBC
Ferguson: This is a Fed that wants to get inflation under control, but recognizes the uncertainty surrounding those plans
CNBC
What investors need to know about the Fed’s March meeting minutes
CNBC
Must consider France’s national interests when it comes to Ukraine, says Le Pen spokesperson
CNBC
Delancey’s Ivory Johnson: Fed’s balance sheet runoff has spooked the markets
CNBC
The Pre-Markets Rundown: April 7, 2022
CNBC
UP NEXT
2. Consumer demand is slated to increase
As great as the last few years have been for cannabis companies in terms of revenue growth and market growth, there’s an extremely powerful trend that’s going to continue making things even better through 2025: exploding consumer demand.
If you are skeptical that demand will keep rising, check out this projection:
© Statista A chart depicting the rising volume of adult-use cannabis product consumption in the U.S.In short, the U.S.-based consumption of adult-use marijuana is going to more than double 2021’s level over the next few years.
That means well-functioning companies like Trulieve have a high chance of continuing to expand their sales at a rapid clip without compromising their earnings growth, especially if they continue to perform bolt-on acquisitions that bolster their ability to meet demand.
On the other hand, investors should be aware that the risk of companies prioritizing revenue growth over profitability and investor rewards is higher than ever. Remember, it’s entirely possible for businesses to grow themselves into an untenable position financially, especially when they’re massively expanding their cultivation and distribution facilities at the same time. And with consumption predicted to increase so much by 2025, it’s hard to blame them for wanting to.
SPONSORED:
Here’s The Marijuana Stock You’ve Been Waiting ForA little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming.
Cannabis legalization is sweeping over North America – 18 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.
And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.
Because a game-changing deal just went down between the Ontario government and this powerhouse company…and you need to hear this story today if you have even considered investing in pot stocks.
Simply click here to get the full story now.
Alex Carchidi has no position in any of the stocks mentioned. The Motley Fool owns and recommends Cresco Labs Inc., OrganiGram Holdings, and Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.
Recent Comments